MediciGlobal Wins Four International 2009 Communications Awards for Patient Recruitment and Retention
PHILADELPHIA and LONDON, June 17 /PRNewswire/ -- MediciGlobal, a leading speciality patient recruitment-retention company, receives four separate Awards of Distinction in The 2009 Communicator Awards from the International Academy of the Visual Arts. The Communicator Awards is the leading international awards program honouring creative excellence for Communications Professionals.
MediciGlobal won awards on behalf of three global pharmaceutical clients in four distinct disease areas:
Depression Promotional Study Site Kit
Menopause Promotional Study Site Kit
Clinically Isolated Syndrome Patient Education Programme
(Pre-diagnosed Multiple Sclerosis)
Teen Migraine Patient Recruitment Campaign
"We know the importance of developing high quality programmes that adhere to health literacy guidelines," says Liz Moench, MediciGlobal's President and CEO. "Study sites rightly expect materials of high quality to hand to their patients," adds Moench.
MediciGlobal knows that recruitment and retention materials are most effective when study researchers and their clinical coordinators are proud to use them, and when patients value the information they provide about clinical trial participation.
Since 2007, the company has received 10 national and international awards for its patient recruitment and retention programmes. These awards recognise MediciGlobal's work in support of CNS, endocrinology, oncology, and infectious disease clinical trials. "Receiving recognition such as this, further attests that our programmes are innovative, patient-friendly and industry-leading," notes Liz Moench.
Winners for the 2009 awards were chosen from over 9,000 world-wide entries, and were judged by the International Academy of the Visual Arts, an invitation-only professional organization consisting of top-tier professionals from leading media, communications, advertising, and marketing firms.
About MediciGlobal
MediciGlobal based in the U.S. and U.K., is a specialty patient recruitment - retention company, developing patient-centric programmes for clinical trials of all sizes, and in countries around the globe. MediciGlobal's patient recruitment and retention programmes ensure that biopharmaceutical and life sciences companies meet or exceed their clinical study timelines. MediciGlobal is one of few companies focused solely on patient recruitment and retention for almost two decades. www.mediciglobal.com.
About The Communicator Awards
The Communicator Awards is the leading international awards program honouring creative excellence for communications professionals. The Communicator Awards is an annual competition honouring the best in advertising, corporate communications, public relations and brand-identity work for print, video, interactive and audio. Visit www.communicatorawards.com for more information.
CONTACT: Lindsey Lewis of MediciGlobal, +1-484-674-6872, llewis@mediciglobal.com
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.